S&P 500   3,941.48
DOW   31,928.62
QQQ   287.24
S&P 500   3,941.48
DOW   31,928.62
QQQ   287.24
S&P 500   3,941.48
DOW   31,928.62
QQQ   287.24
S&P 500   3,941.48
DOW   31,928.62
QQQ   287.24

Spire Healthcare Group (SPI) Share Forecast, Price & News

GBX 217.34
+0.34 (+0.16%)
(As of 05/25/2022 10:18 AM ET)
Today's Range
50-Day Range
52-Week Range
9,097 shs
Average Volume
684,162 shs
Market Capitalization
£871.80 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive SPI News and Ratings via Email

Sign-up to receive the latest news and ratings for Spire Healthcare Group and its competitors with MarketBeat's FREE daily newsletter.

Spire Healthcare Group logo

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments. In addition, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory care, and rheumatology; and scans and investigations, skin treatments, spinal care, sports science, urology care, vascular surgery, weight loss, and women's health. Further, the company offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. It offers diagnostics, in-patient, daycase, and out-patient care services through 40 hospitals and eight clinics across England, Wales, and Scotland. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.


See More Headlines

Industry, Sector and Symbol

Medical Care
Year Founded

Sales & Book Value

Annual Sales
£1.11 billion
Cash Flow
GBX 51.89 per share
Book Value
GBX 177 per share


Pretax Margin




Free Float
Market Cap
£871.80 million
Not Optionable

Company Calendar

Last Earnings


Overall MarketRank

2.18 out of 5 stars

Analyst Opinion: 2.3Community Rank: 4.0Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -

Spire Healthcare Group (LON:SPI) Frequently Asked Questions

Is Spire Healthcare Group a buy right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Spire Healthcare Group in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Spire Healthcare Group stock.
View analyst ratings for Spire Healthcare Group
or view top-rated stocks.

How were Spire Healthcare Group's earnings last quarter?

Spire Healthcare Group plc (LON:SPI) released its quarterly earnings results on Friday, March, 2nd. The company reported $14.40 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $14.60 by $0.20. The company earned $931.70 million during the quarter.
View Spire Healthcare Group's earnings history

What price target have analysts set for SPI?

6 brokerages have issued twelve-month price targets for Spire Healthcare Group's shares. Their forecasts range from GBX 180 to GBX 347. On average, they expect Spire Healthcare Group's stock price to reach GBX 257.17 in the next year. This suggests a possible upside of 18.3% from the stock's current price.
View analysts' price targets for Spire Healthcare Group
or view top-rated stocks among Wall Street analysts.

Who are Spire Healthcare Group's key executives?
Spire Healthcare Group's management team includes the following people:
  • Mr. Justin J. Ash, CEO & Exec. Director
  • Mr. Jitesh Himatlal Sodha, CFO & Exec. Director (Leave of Absence) (Age 54, Pay $855.2k)
  • Harbant Samra, Group Financial Controller & CFO
  • Mr. John Forrest, Chief Operating Officer
  • Angus Prentice, Interim Head of Investor Relations
  • Ms. Shelley Thomas, Group Human Resurces Director
  • Mr. Mathew Mason, Head of Supply Chain & Purchasing (Central)
  • Mr. Peter Corfield, Chief Commercial Officer
  • Philip Davies, Company Sec.
What other stocks do shareholders of Spire Healthcare Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Spire Healthcare Group investors own include Tenet Healthcare (THC), Mediclinic International (MDC), Kindred Biosciences (KIN), Merlin Entertainments (MERL), National Grid (NG), Barclays (BARC), bluebird bio (BLUE), easyJet (EZJ), Hurricane Energy (HUR) and ITV (ITV).

What is Spire Healthcare Group's stock symbol?

Spire Healthcare Group trades on the London Stock Exchange (LON) under the ticker symbol "SPI."

How do I buy shares of Spire Healthcare Group?

Shares of SPI and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Spire Healthcare Group's stock price today?

One share of SPI stock can currently be purchased for approximately GBX 217.34.

How much money does Spire Healthcare Group make?

Spire Healthcare Group has a market capitalization of £871.80 million and generates £1.11 billion in revenue each year.

How many employees does Spire Healthcare Group have?

Spire Healthcare Group employs 12,563 workers across the globe.

What is Spire Healthcare Group's official website?

The official website for Spire Healthcare Group is investors.spirehealthcare.com.

How can I contact Spire Healthcare Group?

Spire Healthcare Group's mailing address is 3 Dorset Rise, LONDON, EC4Y 8EN, United Kingdom. The company can be reached via phone at 44 20 7427 9000.

This page was last updated on 5/25/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.